X
Please Wait
Applying Filters...
01 DR REDDYS LABS SA (4)
01 TABLET;ORAL (4)
01 RX (4)
01 EZETIMIBE AND SIMVASTATIN (4)
01 No (4)
19
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is EZETIMIBE; SIMVASTATIN, with a corresponding application number 200909.
Regulatory Information RX
With a dosage strength 10MG;40MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2017-04-26
Therapeutic Equivalence (TE) Code AB
18
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is EZETIMIBE; SIMVASTATIN, with a corresponding application number 200909.
Regulatory Information RX
With a dosage strength 10MG;10MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2017-04-26
Therapeutic Equivalence (TE) Code AB
17
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is EZETIMIBE; SIMVASTATIN, with a corresponding application number 200909.
Regulatory Information RX
With a dosage strength 10MG;80MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2017-04-26
Therapeutic Equivalence (TE) Code AB
16
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is EZETIMIBE; SIMVASTATIN, with a corresponding application number 200909.
Regulatory Information RX
With a dosage strength 10MG;20MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2017-04-26
Therapeutic Equivalence (TE) Code AB
Market Place
KEY PRODUCTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
